CIP
GMED icon

Convergence Investment Partners’s Globus Medical GMED Stock Holding History

Convergence Investment Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,132
Closed -$2.17M – 261
2026
Q1 		$2.17M Buy
+25,132
New +$2.26M 0.35% 91
2017
Q4 		– Sell
-25,170
Closed -$748K – 314
2017
Q3 		$748K Buy
+25,170
New +$769K 0.11% 252
2016
Q4 		– Sell
-18,417
Closed -$416K – 341
2016
Q3 		$416K Buy
+18,417
New +$433K 0.06% 297
2014
Q4 		– Sell
-110,730
Closed -$2.18M – 389
2014
Q3 		$2.18M Buy
+110,730
New +$2.28M 0.3% 129

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Convergence Investment Partners's GMED Position: Q2 2026 in Review

Convergence Investment Partners sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 25,132 shares — an estimated $2.17M sold.

Convergence Investment Partners first reported a position in GMED in Q3 2014 and held it in 4 quarters. The position peaked at $2.18M in Q3 2014. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Convergence Investment Partners reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Convergence Investment Partners sold 25,132 Globus Medical shares in Q2 2026, an estimated $2.17M.
  • Convergence Investment Partners first reported a position in Globus Medical in Q3 2014 and held it in 4 quarters.
  • Convergence Investment Partners's Globus Medical position peaked at $2.18M in Q3 2014.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.